Search Results - Isabelle Desombere

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Cover Image

    SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of... by Milena Callies, Ines Kabouche, Isabelle Desombere, Joanna Merckx, Mathieu Roelants, Melissa Vermeulen, Els Duysburgh

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022 by Johan Van der Heyden, Victoria Leclercq, Els Duysburgh, Laura Cornelissen, Isabelle Desombere, Inge Roukaerts, Lydia Gisle

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. by Maria E. Goossens, Kristof Y. Neven, Pieter Pannus, Cyril Barbezange, Isabelle Thomas, Steven Van Gucht, Katelijne Dierick, Marie-Noëlle Schmickler, Mathieu Verbrugghe, Nele Van Loon, Kevin K Ariën, Arnaud Marchant, Stanislas Goriely, Isabelle Desombere

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 4
    Cover Image

    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial. by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K Ariën, Maria E Goossens

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  5. 5
    Cover Image

    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y. Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K. Ariën, Maria E. Goossens

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: